Sven Anders Liljeblad
Président chez Chundsell Medicals AB
Profil
Sven Anders Liljeblad is currently the Chairman at Chundsell Medicals AB since 2017.
He previously worked as an Independent Director at Digitalist Group Oyj.
Postes actifs de Sven Anders Liljeblad
| Sociétés | Poste | Début |
|---|---|---|
Chundsell Medicals AB
 Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Président | 01/01/2017 |
Anciens postes connus de Sven Anders Liljeblad
| Sociétés | Poste | Fin |
|---|---|---|
| DIGITALIST GROUP PLC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIGITALIST GROUP PLC | Technology Services |
| Entreprise privées | 1 |
|---|---|
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Health Technology |
